After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology / C. Borsari, D.J. Trader, A. Tait, M.P. Costi. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 63:5(2020 Mar 12), pp. 1908-1928. [10.1021/acs.jmedchem.9b01456]

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology

C. Borsari
Primo
;
2020

Abstract

After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.
English
Settore CHIM/08 - Chimica Farmaceutica
Articolo
Esperti anonimi
Pubblicazione scientifica
12-mar-2020
American Chemical Society
63
5
1908
1928
21
Pubblicato
Periodico con rilevanza internazionale
scopus
orcid
crossref
wos
datacite
Aderisco
info:eu-repo/semantics/article
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology / C. Borsari, D.J. Trader, A. Tait, M.P. Costi. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 63:5(2020 Mar 12), pp. 1908-1928. [10.1021/acs.jmedchem.9b01456]
open
Prodotti della ricerca::01 - Articolo su periodico
4
262
Article (author)
Periodico con Impact Factor
C. Borsari, D.J. Trader, A. Tait, M.P. Costi
File in questo prodotto:
File Dimensione Formato  
26_2020_JMC_perspetive.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 4.86 MB
Formato Adobe PDF
4.86 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1017116
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 31
social impact